Cidara Therapeutics, Inc. (CDTX)

Cidara Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	189.83	35.78	32.73	59.68	35.91
Cash & Short-Term Investments	189.83	35.78	32.73	59.68	35.91
Cash Growth	430.56%	9.31%	-45.16%	66.18%	-28.56%
Accounts Receivable	1.69	14.08	5.72	5.36	11.18
Receivables	1.69	14.08	5.72	5.36	11.18
Prepaid Expenses	12.87	1.71	5.58	4.07	3.07
Restricted Cash	6.35	-	-	2.59	7.04
Other Current Assets	-	9.29	1.07	-	-
Total Current Assets	210.74	60.86	45.09	71.7	57.19
Property, Plant & Equipment	3.96	5.13	1.32	2.54	1.21
Other Long-Term Assets	0.1	1.05	1.07	1.08	2.02
Total Assets	214.8	67.03	47.49	75.33	60.42
Accounts Payable	3.61	3.77	1.45	1.3	4.57
Accrued Expenses	44.3	37.25	24.13	15.06	12.17
Current Portion of Long-Term Debt	-	-	-	2.59	7.02
Current Portion of Leases	1.64	1.3	1.21	1.15	0.94
Current Unearned Revenue	-	0.43	1	13.92	13.87
Other Current Liabilities	-	24.67	13.61	-	-
Total Current Liabilities	49.55	67.42	41.4	34.02	38.56
Long-Term Leases	1.93	3.58	-	1.32	-
Long-Term Unearned Revenue	-	-	-	18.41	11.15
Other Long-Term Liabilities	-	4.25	20.53	-	-
Total Liabilities	51.49	75.24	61.93	53.75	49.71
Common Stock	0	0	0	0.01	0
Additional Paid-In Capital	774.57	433.22	404.06	398.73	345.41
Retained Earnings	-611.26	-441.43	-418.5	-377.17	-334.7
Total Common Equity	163.31	-8.21	-14.44	21.57	10.72
Shareholders' Equity	163.31	-8.21	-14.44	21.57	10.72
Total Liabilities & Equity	214.8	67.03	47.49	75.33	60.42
Total Debt	3.58	4.88	1.21	5.06	7.96
Net Cash (Debt)	186.25	30.9	31.52	54.62	27.95
Net Cash Growth	502.73%	-1.96%	-42.29%	95.42%	-27.48%
Net Cash Per Share	29.33	7.07	9.02	20.83	13.45
Filing Date Shares Outstanding	10.95	10.95	4.45	3.41	2.4
Total Common Shares Outstanding	10.95	4.53	3.62	3.39	2.24
Working Capital	161.18	-6.56	3.69	37.68	18.63
Book Value Per Share	14.92	-1.81	-3.98	6.36	4.78
Tangible Book Value	163.31	-8.21	-14.44	21.57	10.72
Tangible Book Value Per Share	14.92	-1.81	-3.98	6.36	4.78
Machinery	3.44	3.32	2.96	3.06	2.97
Leasehold Improvements	0.43	0.43	0.43	0.43	0.43

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q